Axiom Investors LLC Supernus Pharmaceuticals, Inc. Transaction History
Axiom Investors LLC
- $11.3 Billion
- Q2 2024
A detailed history of Axiom Investors LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Axiom Investors LLC holds 54,860 shares of SUPN stock, worth $1.86 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
54,860
Previous 54,235
1.15%
Holding current value
$1.86 Million
Previous $1.85 Million
20.66%
% of portfolio
0.01%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding SUPN
# of Institutions
263Shares Held
59.4MCall Options Held
47.9KPut Options Held
13.1K-
Black Rock Inc. New York, NY10.4MShares$353 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.14MShares$208 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.27MShares$179 Million1.83% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.87MShares$97.4 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.68MShares$91 Million0.08% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.82B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...